Adicet Bio, Inc. (ACET)
How ACET actually reacts to news — the realized, point-in-time move the market made, measured across 288 labeled events over the last three years with zero look-ahead.
ACET’s median reaction, across the day.
Half of all Adicet Bio, Inc. news events land between -3.19% and +1.21% at 30 minutes.
Reaction stats as of 2026-08-18. Reaction = percent move vs. the price at the news timestamp.
Email me when ACET moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ACET’s baseline. Nothing else.
Get “How ACET reacts to news” as a PDF.
A free one-page summary: ACET’s median reaction to news and the full breakdown by event type — the numbers on this page, in one page.
Recent ACET events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates | Press release | Business Wire | -8.61% | -8.96% | |
| Form 10-Q Adicet Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -8.61% | -8.96% | |
| Form 8-K Adicet Bio, Inc. For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | -8.61% | -8.96% | |
| Adicet Bio to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference | Press release | Business Wire | +0.12% | +6.20% | |
| Form 8-K Adicet Bio, Inc. For: Jun 17 | SEC filing · Form 8-K | SEC EDGAR | +0.99% | +1.86% | |
| Form 10-K/A Adicet Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -0.78% | +2.33% | |
| Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference | Press release | Business Wire | -2.91% | -6.91% | |
| Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates | Press release | Business Wire | +0.61% | +3.19% | |
| Form 10-Q Adicet Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.61% | +3.19% | |
| Form 8-K Adicet Bio, Inc. For: May 13 | SEC filing · Form 8-K | SEC EDGAR | +0.61% | +3.19% | |
| Form S-8 POS Adicet Bio, Inc. | SEC filing · Form S-8 | SEC EDGAR | +0.61% | +3.19% | |
| Form ARS Adicet Bio, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.00% | -0.66% | |
| Form DEF 14A Adicet Bio, Inc. For: Apr 29 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -0.66% | |
| Form DEFA14A Adicet Bio, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | -0.66% | |
| Form 8-K Adicet Bio, Inc. For: Apr 27 | SEC filing · Form 8-K | SEC EDGAR | -0.65% | -0.13% | |
| Form EFFECT Adicet Bio, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +1.97% | +1.52% | |
| Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress | Press release | Business Wire | +9.17% | +3.29% | |
| Form 10-K Adicet Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +9.17% | +3.29% | |
| Form 8-K Adicet Bio, Inc. For: Mar 12 | SEC filing · Form 8-K | SEC EDGAR | +9.17% | +3.29% | |
| Form S-3 Adicet Bio, Inc. | SEC filing · Form S-3 | SEC EDGAR | +9.17% | +3.29% | |
| Form S-8 Adicet Bio, Inc. | SEC filing · Form S-8 | SEC EDGAR | +9.17% | +3.29% | |
| Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 | Press release | Business Wire | +0.12% | -4.99% | |
| Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones | Press release | Business Wire | +0.00% | +4.71% | |
| Form 8-K Adicet Bio, Inc. For: Jan 07 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +4.71% | |
| Form 8-K Adicet Bio, Inc. For: Dec 26 | SEC filing · Form 8-K | SEC EDGAR | +0.46% | -1.95% | |
| Adicet Bio Announces Reverse Stock Split | Press release | Business Wire | +4.62% | +10.40% | |
| Form 8-K Adicet Bio, Inc. For: Dec 19 | SEC filing · Form 8-K | SEC EDGAR | -0.51% | +0.37% | |
| Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) | Press release | Business Wire | — | +0.00% | |
| Form DEF 14A Adicet Bio, Inc. For: Dec 19 | SEC filing · Form DEF | SEC EDGAR | -6.60% | -5.69% | |
| Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates | Press release | Business Wire | +0.01% | -1.91% | |
| Form 10-Q Adicet Bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.01% | -1.91% | |
| Form 8-K Adicet Bio, Inc. For: Nov 05 | SEC filing · Form 8-K | SEC EDGAR | +0.01% | -1.91% | |
| Form PRE 14A Adicet Bio, Inc. For: Dec 19 | SEC filing · Form PRE | SEC EDGAR | +0.01% | -1.91% | |
| Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | Press release | Business Wire | -1.07% | -2.67% | |
| Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference | Press release | Business Wire | -4.06% | -5.98% | |
| Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA) | Press release | Business Wire | +1.96% | +1.96% | |
| Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE) | Press release | Business Wire | +0.81% | -9.85% | |
| Adicet Bio, Inc. Announces $80 Million Registered Direct Offering | Press release | Business Wire | +0.81% | -9.85% | |
| Form 8-K Adicet Bio, Inc. For: Oct 07 | SEC filing · Form 8-K | SEC EDGAR | +0.81% | -9.85% | |
| Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) | Press release | Business Wire | +1.51% | +2.77% | |
| Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference | Press release | Business Wire | -0.52% | +0.60% | |
| Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | Press release | Business Wire | -0.52% | +0.60% | |
| Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates | Press release | Business Wire | +1.42% | -8.68% | |
| Form 10-Q Adicet Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.42% | -8.68% | |
| Form 8-K Adicet Bio, Inc. For: Aug 07 | SEC filing · Form 8-K | SEC EDGAR | +1.42% | -8.68% | |
| Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference | Press release | Business Wire | +2.10% | +2.10% | |
| Form S-8 Adicet Bio, Inc. | SEC filing · Form S-8 | SEC EDGAR | -1.66% | -2.68% | |
| Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases | Press release | Business Wire | -0.99% | -3.04% | |
| Form 8-K Adicet Bio, Inc. For: Jul 22 | SEC filing · Form 8-K | SEC EDGAR | -0.99% | -3.04% | |
| Form 8-K Adicet Bio, Inc. For: Jun 11 | SEC filing · Form 8-K | SEC EDGAR | +0.69% | -3.24% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ACET section they belong to.
More of the dataset.
ACET earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Adicet Bio, Inc.'s median reaction calculated?
Every labeled ACET news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 288 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 37% of ACET's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-08-18.
Does ACET's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.